Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
New Strategies for the Treatment of Atrial Fibrillation.

Pharmaceuticals (Basel, Switzerland)

Jost N, Christ T, Magyar J.
PMID: 34577626
Pharmaceuticals (Basel). 2021 Sep 15;14(9). doi: 10.3390/ph14090926.

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It significantly contributes to the morbidity and mortality of the elderly population. Over the past 25-30 years intense effort in basic research has advanced the understanding...

Cite
Jost N, Christ T, Magyar J. New Strategies for the Treatment of Atrial Fibrillation. Pharmaceuticals (Basel). 2021;14(9)doi: 10.3390/ph14090926.
Jost, N., Christ, T., & Magyar, J. (2021). New Strategies for the Treatment of Atrial Fibrillation. Pharmaceuticals (Basel, Switzerland), 14(9), . https://doi.org/10.3390/ph14090926
Jost, Norbert, et al. "New Strategies for the Treatment of Atrial Fibrillation." Pharmaceuticals (Basel, Switzerland) vol. 14,9 (2021). doi: https://doi.org/10.3390/ph14090926
Jost N, Christ T, Magyar J. New Strategies for the Treatment of Atrial Fibrillation. Pharmaceuticals (Basel). 2021 Sep 15;14(9). doi: 10.3390/ph14090926. PMID: 34577626; PMCID: PMC8466466.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries